AU3261097A - Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders - Google Patents
Piperidine acetic acid derivatives and their use in the treatment of thrombotic disordersInfo
- Publication number
- AU3261097A AU3261097A AU32610/97A AU3261097A AU3261097A AU 3261097 A AU3261097 A AU 3261097A AU 32610/97 A AU32610/97 A AU 32610/97A AU 3261097 A AU3261097 A AU 3261097A AU 3261097 A AU3261097 A AU 3261097A
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- acetic acid
- acid derivatives
- thrombotic disorders
- piperidine acetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9613018 | 1996-06-21 | ||
| GB9613017 | 1996-06-21 | ||
| GBGB9613018.2A GB9613018D0 (en) | 1996-06-21 | 1996-06-21 | Therapeutic indazoles |
| GBGB9613026.5A GB9613026D0 (en) | 1996-06-21 | 1996-06-21 | Heterocyclic compounds |
| GBGB9613095.0A GB9613095D0 (en) | 1996-06-21 | 1996-06-21 | Therapeutic piperidines |
| GB9613095 | 1996-06-21 | ||
| GBGB9613017.4A GB9613017D0 (en) | 1996-06-21 | 1996-06-21 | Therapeutic compounds |
| GB9613026 | 1996-06-21 | ||
| PCT/EP1997/003194 WO1997049698A1 (fr) | 1996-06-21 | 1997-06-19 | Derives d'acide acetique de piperidine et leur utilisation dans le traitement des troubles thrombotiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3261097A true AU3261097A (en) | 1998-01-14 |
Family
ID=27451466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU32610/97A Abandoned AU3261097A (en) | 1996-06-21 | 1997-06-19 | Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU3261097A (fr) |
| WO (1) | WO1997049698A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6133290A (en) * | 1998-07-31 | 2000-10-17 | Eli Lilly And Company | 5-HT1F agonists |
| JP4307073B2 (ja) * | 2000-12-22 | 2009-08-05 | ワイス | ５−ヒドロキシトリプトアミン−６リガンドとしてのヘテロサイクルインダゾールおよびアザインダゾール化合物 |
| WO2003000685A1 (fr) * | 2001-06-20 | 2003-01-03 | Takeda Chemical Industries, Ltd. | Derives heterocycliques a 5 chainons |
| US7355042B2 (en) | 2001-10-16 | 2008-04-08 | Hypnion, Inc. | Treatment of CNS disorders using CNS target modulators |
| TW200401641A (en) | 2002-07-18 | 2004-02-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands |
| TW200403243A (en) | 2002-07-18 | 2004-03-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| PL377848A1 (pl) | 2003-02-07 | 2006-02-20 | Daiichi Pharmaceutical Co., Ltd. | Pochodne pirazoli |
| ATE461925T1 (de) | 2005-04-26 | 2010-04-15 | Hypnion Inc | Benzisoxazolpiperidinverbindungen und verfahren zu deren anwendung |
| RU2008127501A (ru) | 2006-01-13 | 2010-02-20 | Вайет (Us) | Сульфонилзамещенные 1н-индолы в качастве лигандов 5-гидрокситриптаминовых рецепторов |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4124942A1 (de) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| JPH07501063A (ja) * | 1991-11-14 | 1995-02-02 | グラクソ、グループ、リミテッド | フィブリノーゲン依存性血小板凝集阻害剤としてのピペリジン酢酸誘導体 |
| GB9208740D0 (en) * | 1992-04-23 | 1992-06-10 | Glaxo Group Ltd | Chemical compounds |
| IL110172A (en) * | 1993-07-22 | 2001-10-31 | Lilly Co Eli | Bicycle compounds and pharmaceuticals containing them |
-
1997
- 1997-06-19 AU AU32610/97A patent/AU3261097A/en not_active Abandoned
- 1997-06-19 WO PCT/EP1997/003194 patent/WO1997049698A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997049698A1 (fr) | 1997-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3866597A (en) | Propionic acid derivatives and use thereof | |
| AU6974996A (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
| AU3339897A (en) | Sulphonamide derivatives and their use in the treatment of cns disorders | |
| AU3102097A (en) | Spiro-piperidine derivatives and their use as therapeutic agents | |
| AU2103097A (en) | Cinnoline derivatives and use as medicine | |
| AU3725997A (en) | S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders | |
| AU4171500A (en) | Flupirtine in the treatment of fibromyalgia and related conditions | |
| AU1732395A (en) | Certain cerulenin-geranyl and dodecanoic acid derivatives | |
| AU4342989A (en) | Mercapto-acylamino acids useful in the treatment of cardiovascular disorders and as analgesics | |
| AU2655097A (en) | Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents | |
| AU4061597A (en) | Treatment of the common cold or allergic rhinitis | |
| AU4161797A (en) | Benzoperimidine-carboxylic acids and derivatives thereof | |
| AU5967896A (en) | Peptidyl heterocycles useful in the treatment of thrombin re lated disorders | |
| AU7606596A (en) | The use of aliphatic carboxylic acid derivatives in ophthalmic disorders | |
| AU2626895A (en) | Production and uses of caffeic acid and derivatives thereof | |
| AU2058697A (en) | Treatment of sleep disorders | |
| AU3099997A (en) | The use of tcet in the prophylaxis and treatment of allergies | |
| AU3261097A (en) | Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders | |
| ZA973098B (en) | Novel carboxylic acid derivatives their preparation and use | |
| AU5836498A (en) | N-acyl-hydroxyamino acid esters and their use | |
| ZA973096B (en) | Novel carboxylic acid derivatives their preparation and use | |
| AU3268197A (en) | Spiro-piperidine derivatives and their use as therapeutic agents | |
| IL127464A0 (en) | Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders | |
| AU3114295A (en) | Methods of prognosing the course and degree of dementia in patients with beta-amyloid-related diseases | |
| AU2554595A (en) | Compositions and uses thereof in the diagnosis of psoriasis |